GlassScriptPhysician profile
Abbey Woods
NPI 1417396516
$480.71
in general payments reported to CMS, 2019-2025
9 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $164 · 2023: $77.99 · 2024: $72.57 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.30 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $84.99 | 2022 | |
| Abbvie INC. | $84.07 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $69.49 | 2025 | Caplyta |
| Lilly USA, LLC | $55.91 | 2022-2025 | Zepbound, Mounjaro, Trulicity |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Glaxosmithkline, LLC. | $47.93 | 2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $45.19 | 2024-2025 | Airsupra |
| Novo Nordisk INC | $29.93 | 2023-2024 | Wegovy |
| Abbott Laboratories | $13.20 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbey Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.